Related Experiment Videos
Fibronectin in fulminant hepatic failure.
British Medical Journal (Clinical Research Ed.)
|October 30, 1982
Summary
Fulminant hepatic failure patients often show low plasma fibronectin levels. This reduction may impair Kupffer cell function, impacting liver health.
Area of Science:
- Hepatology
- Immunology
Background:
- Fulminant hepatic failure (FHF) is a severe clinical syndrome.
- Kupffer cells play a crucial role in liver immune surveillance and debris clearance.
Purpose of the Study:
- To investigate plasma fibronectin concentrations in patients with FHF.
- To explore the relationship between fibronectin levels, liver injury markers, and Kupffer cell function.
Main Methods:
- Measurement of plasma fibronectin concentrations in 17 FHF patients.
- Correlation analysis between fibronectin levels and aspartate aminotransferase (AST) activity.
Main Results:
- 13 out of 17 FHF patients had below-normal plasma fibronectin (<194–472 µg/ml).
- Mean fibronectin concentration was significantly reduced (117.9 ± 19.4 µg/ml).
- A negative correlation was observed between fibronectin and AST, suggesting fibronectin consumption.
Conclusions:
- Reduced plasma fibronectin is common in FHF.
- Fibronectin consumption may occur during hepatocyte debris clearance.
- Low fibronectin availability could contribute to impaired Kupffer cell function in FHF.